Health
Johnson & Johnson’s Experimental COVID-19 Vaccine Protects Monkeys in a Single Dose, US Firm Kicks-Off – LatestLY
Amid the reports of 4.5 million people affected from COVID-19 in the United States, Johnson & Johnson on Thursday initiated US human safety trials for its COVID-19 vaccine. The coronavirus vaccine trials were kicked off after study in monkeys showed J&…
Chicago, July 30: Amid the reports of 4.5 million people affected from COVID-19 in the United States, Johnson & Johnson on Thursday initiated US human safety trials for its COVID-19 vaccine. The coronavirus vaccine trials were kicked off after study in monkeys showed J&J’s best-performing vaccine candidate offered strong protection in a single dose.
According to a report, published in Reuters, six out of six monkeys were found completely protected from lung disease. Also, five out of th…
-
General21 hours agoNothing to see here *wink wink*
-
General20 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
General23 hours agoThis isn’t progress, it’s punishment
-
General22 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I